ImmuCell Corporation Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)
ImmuCell Corporation (ICCC) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of $17.64 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Notes › Receivables › and Others
us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2017-11-13
- ImmuCell Corporation accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2017-09-30 was $232.00.
- ImmuCell Corporation accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2017-06-30 was $18.49K.
- ImmuCell Corporation accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2017-03-31 was -$1.08K.
- ImmuCell Corporation accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2016-12-31 was -$1.01K, a 137.90% decline year-over-year.
- ImmuCell Corporation accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2016 was -$3.23K, a 270.39% decline from fiscal 2015.
- ImmuCell Corporation accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2015 was $1.90K.
- ImmuCell Corporation accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2014 was -$2.24K, a 293.44% decline from fiscal 2013.
- ImmuCell Corporation accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2013 was $1.16K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 3 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 6 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 9 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2017-09-30 | $232.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $18.72K derived: sum of 2 quarters · filed 2017-11-13 | $17.64K 10-Q · filed 2017-11-13 | $16.63K derived: sum of 4 quarters · filed 2017-11-13 |
| 2017-06-30 | $18.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $17.41K 10-Q · filed 2017-08-14 | $16.40K derived: sum of 3 quarters · filed 2017-08-14 | $15.73K derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | -$1.08K 10-Q · filed 2017-05-11 | -$2.09K derived: sum of 2 quarters · filed 2017-05-11 | -$2.77K derived: sum of 3 quarters · filed 2017-05-11 | -$3.75K derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-12-31 | -$1.01K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | -$1.69K derived: sum of 2 quarters · filed 2017-03-30 | -$2.67K derived: sum of 3 quarters · filed 2017-03-30 | -$3.23K 10-K · filed 2017-03-30 |
| 2016-09-30 | -$676.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$1.67K derived: sum of 2 quarters · filed 2016-11-10 | -$2.23K 10-Q · filed 2016-11-10 | $437.00 derived: sum of 4 quarters · filed 2016-11-10 |
| 2016-06-30 | -$989.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$1.55K 10-Q · filed 2016-08-11 | $1.11K derived: sum of 3 quarters · filed 2016-08-11 | $732.00 derived: sum of 4 quarters · filed 2016-08-11 |
| 2016-03-31 | -$560.00 10-Q · filed 2016-05-11 | $2.10K derived: sum of 2 quarters · filed 2016-05-11 | $1.72K derived: sum of 3 quarters · filed 2016-05-11 | $1.78K derived: sum of 4 quarters · filed 2016-05-11 |
| 2015-12-31 | $2.66K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $2.28K derived: sum of 2 quarters · filed 2016-03-25 | $2.34K derived: sum of 3 quarters · filed 2016-03-25 | $1.90K 10-K · filed 2016-03-25 |
| 2015-09-30 | -$381.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$321.00 derived: sum of 2 quarters · filed 2015-11-12 | -$764.00 10-Q · filed 2015-11-12 | -$4.76K derived: sum of 4 quarters · filed 2015-11-12 |
| 2015-06-30 | $60.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$383.00 10-Q · filed 2015-08-13 | -$4.38K derived: sum of 3 quarters · filed 2015-08-13 | -$3.16K derived: sum of 4 quarters · filed 2015-08-13 |
| 2015-03-31 | -$443.00 10-Q · filed 2015-05-12 | -$4.44K derived: sum of 2 quarters · filed 2015-05-12 | -$3.22K derived: sum of 3 quarters · filed 2015-05-12 | -$2.44K derived: sum of 4 quarters · filed 2015-05-12 |
| 2014-12-31 | -$3.99K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | -$2.77K derived: sum of 2 quarters · filed 2015-03-26 | -$1.99K derived: sum of 3 quarters · filed 2015-03-26 | -$2.24K 10-K · filed 2015-03-26 |
| 2014-09-30 | $1.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $2.00K derived: sum of 2 quarters · filed 2014-11-12 | $1.75K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $780.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $531.00 10-Q · filed 2014-08-13 | ||
| 2014-03-31 | -$249.00 10-Q · filed 2014-05-14 | |||
| 2013-12-31 | $1.16K 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |